CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. High threat of new entrants
3.3.3. High threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in demand for remote healthcare
3.4.1.2. Technological advancement in telemedicine
3.4.2. Restraints
3.4.2.1. Poor infrastructure and connectivity limitations
3.4.3. Opportunities
3.4.3.1. Increase in government initiatives and policies
CHAPTER 4: TELEMEDICINE MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Software
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Hardware
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: TELEMEDICINE MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Teleradiology
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Telepsychiatry
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Telepathology
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Teledermatology
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Telecardiology
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
5.7. Other Applications
5.7.1. Key market trends, growth factors and opportunities
5.7.2. Market size and forecast, by region
5.7.3. Market share analysis by country
CHAPTER 6: TELEMEDICINE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Healthcare Provider
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Payer
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Healthcare Consumers
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: TELEMEDICINE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Component
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Component
7.2.5.1.2. Market size and forecast, by Application
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Component
7.2.5.2.2. Market size and forecast, by Application
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Component
7.2.5.3.2. Market size and forecast, by Application
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Component
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Component
7.3.5.1.2. Market size and forecast, by Application
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Component
7.3.5.2.2. Market size and forecast, by Application
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Component
7.3.5.3.2. Market size and forecast, by Application
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Component
7.3.5.4.2. Market size and forecast, by Application
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Component
7.3.5.5.2. Market size and forecast, by Application
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Component
7.3.5.6.2. Market size and forecast, by Application
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Component
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Component
7.4.5.1.2. Market size and forecast, by Application
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Component
7.4.5.2.2. Market size and forecast, by Application
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Component
7.4.5.3.2. Market size and forecast, by Application
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Component
7.4.5.4.2. Market size and forecast, by Application
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Component
7.4.5.5.2. Market size and forecast, by Application
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Component
7.4.5.6.2. Market size and forecast, by Application
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Component
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Component
7.5.5.1.2. Market size and forecast, by Application
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Component
7.5.5.2.2. Market size and forecast, by Application
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Component
7.5.5.3.2. Market size and forecast, by Application
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Component
7.5.5.4.2. Market size and forecast, by Application
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. AMC Health, LLC
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Key strategic moves and developments
9.2. American Well Corporation
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Oracle Corporation
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. General Electric Company
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Koninklijke Philips N.V.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. The Cigna Group
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Teladoc Health Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Medtronic plc
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Included Health Inc.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Siemens AG
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
TABLE 01. GLOBAL TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 02. TELEMEDICINE MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
TABLE 03. TELEMEDICINE MARKET FOR HARDWARE, BY REGION, 2022-2032 ($MILLION)
TABLE 04. TELEMEDICINE MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 06. TELEMEDICINE MARKET FOR TELERADIOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 07. TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY REGION, 2022-2032 ($MILLION)
TABLE 08. TELEMEDICINE MARKET FOR TELEPATHOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 09. TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 10. TELEMEDICINE MARKET FOR TELECARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 11. TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 13. TELEMEDICINE MARKET FOR HEALTHCARE PROVIDER, BY REGION, 2022-2032 ($MILLION)
TABLE 14. TELEMEDICINE MARKET FOR PAYER, BY REGION, 2022-2032 ($MILLION)
TABLE 15. TELEMEDICINE MARKET FOR HEALTHCARE CONSUMERS, BY REGION, 2022-2032 ($MILLION)
TABLE 16. TELEMEDICINE MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA TELEMEDICINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 21. U.S. TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 22. U.S. TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 23. U.S. TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 24. CANADA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 25. CANADA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 26. CANADA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 27. MEXICO TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 28. MEXICO TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 29. MEXICO TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 30. EUROPE TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 31. EUROPE TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 32. EUROPE TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. EUROPE TELEMEDICINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 34. GERMANY TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 35. GERMANY TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 36. GERMANY TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. FRANCE TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 38. FRANCE TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 39. FRANCE TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 40. UK TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 41. UK TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 42. UK TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 43. ITALY TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 44. ITALY TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. ITALY TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. SPAIN TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 47. SPAIN TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 48. SPAIN TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 51. REST OF EUROPE TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. ASIA-PACIFIC TELEMEDICINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 56. JAPAN TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 57. JAPAN TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. JAPAN TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. CHINA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 60. CHINA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 61. CHINA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 62. INDIA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 63. INDIA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 64. INDIA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 65. AUSTRALIA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 66. AUSTRALIA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 67. AUSTRALIA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 70. SOUTH KOREA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 74. LAMEA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 75. LAMEA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. LAMEA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 77. LAMEA TELEMEDICINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 78. BRAZIL TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 79. BRAZIL TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 80. BRAZIL TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. SAUDI ARABIA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 86. SOUTH AFRICA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 89. REST OF LAMEA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 90. AMC HEALTH, LLC: KEY EXECUTIVES
TABLE 91. AMC HEALTH, LLC: COMPANY SNAPSHOT
TABLE 92. AMC HEALTH, LLC: PRODUCT SEGMENTS
TABLE 93. AMC HEALTH, LLC: SERVICE SEGMENTS
TABLE 94. AMC HEALTH, LLC: PRODUCT PORTFOLIO
TABLE 95. AMC HEALTH, LLC: KEY STRATERGIES
TABLE 96. AMERICAN WELL CORPORATION: KEY EXECUTIVES
TABLE 97. AMERICAN WELL CORPORATION: COMPANY SNAPSHOT
TABLE 98. AMERICAN WELL CORPORATION: SERVICE SEGMENTS
TABLE 99. AMERICAN WELL CORPORATION: PRODUCT PORTFOLIO
TABLE 100. AMERICAN WELL CORPORATION: KEY STRATERGIES
TABLE 101. ORACLE CORPORATION: KEY EXECUTIVES
TABLE 102. ORACLE CORPORATION: COMPANY SNAPSHOT
TABLE 103. ORACLE CORPORATION: SERVICE SEGMENTS
TABLE 104. ORACLE CORPORATION: PRODUCT PORTFOLIO
TABLE 105. GENERAL ELECTRIC COMPANY: KEY EXECUTIVES
TABLE 106. GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
TABLE 107. GENERAL ELECTRIC COMPANY: PRODUCT SEGMENTS
TABLE 108. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
TABLE 109. GENERAL ELECTRIC COMPANY: KEY STRATERGIES
TABLE 110. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 111. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 112. KONINKLIJKE PHILIPS N.V.: SERVICE SEGMENTS
TABLE 113. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 114. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 115. THE CIGNA GROUP: KEY EXECUTIVES
TABLE 116. THE CIGNA GROUP: COMPANY SNAPSHOT
TABLE 117. THE CIGNA GROUP: SERVICE SEGMENTS
TABLE 118. THE CIGNA GROUP: PRODUCT PORTFOLIO
TABLE 119. TELADOC HEALTH INC.: KEY EXECUTIVES
TABLE 120. TELADOC HEALTH INC.: COMPANY SNAPSHOT
TABLE 121. TELADOC HEALTH INC.: SERVICE SEGMENTS
TABLE 122. TELADOC HEALTH INC.: PRODUCT PORTFOLIO
TABLE 123. TELADOC HEALTH INC.: KEY STRATERGIES
TABLE 124. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 125. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 126. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 127. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 128. MEDTRONIC PLC: KEY STRATERGIES
TABLE 129. INCLUDED HEALTH INC.: KEY EXECUTIVES
TABLE 130. INCLUDED HEALTH INC.: COMPANY SNAPSHOT
TABLE 131. INCLUDED HEALTH INC.: SERVICE SEGMENTS
TABLE 132. INCLUDED HEALTH INC.: PRODUCT PORTFOLIO
TABLE 133. SIEMENS AG: KEY EXECUTIVES
TABLE 134. SIEMENS AG: COMPANY SNAPSHOT
TABLE 135. SIEMENS AG: PRODUCT SEGMENTS
TABLE 136. SIEMENS AG: PRODUCT PORTFOLIO
TABLE 137. SIEMENS AG: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/